The ANP32B Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for functional analysis of the ANP32B gene in a T lymphocyte context. This heterogeneous loss-of-function pool, generated in Jurkat cells, provides a versatile model for investigating ANP32B-dependent processes without clonal selection, enabling robust assessment of gene function in apoptosis and leukemia research.
Jurkat cells originate from the peripheral blood of a 14-year-old male with acute T cell leukemia, serving as a classic immortalized T lymphocyte line for studying T cell signaling, leukemogenesis, and apoptosis. Their well-characterized signaling network makes them an ideal host for dissecting ANP32B functions, particularly in the context of caspase activation and cellular stress pathways.
ANP32B encodes a histone chaperone and apoptosis inhibitor that suppresses caspase-3 (CASP3) activation and facilitates mRNA nuclear export. Upstream, its activity is regulated by MYC and CK2 kinase in response to cellular stress signals. ANP32B interacts with SET, importin beta, and histones to modulate chromatin structure and directly inhibits CASP3 within the caspase cascade. It also associates with BCL2 family proteins, thereby integrating intrinsic apoptotic signaling. This multifunctional role positions ANP32B as a key coordinator of chromatin dynamics, apoptosis, and nucleocytoplasmic transport.
Disruption of ANP32B in Jurkat cells eliminates its anti-apoptotic function, enhancing sensitivity to death-inducing stimuli and altering histone chaperone dynamics. This sensitization is highly relevant for studying drug resistance and leukemic cell survival, as ANP32B is often dysregulated in cancer. The knockout model enables detailed investigation of caspase cascade activation, histone methylation, and mRNA transport crosstalk, providing a physiologically relevant system to explore therapeutic vulnerabilities and the interplay between apoptosis and epigenetic regulation in T cell malignancies.
Typical applications span apoptosis regulation, T cell leukemia biology, drug resistance mechanisms, histone chaperone function, and nucleocytoplasmic transport. Experimental approaches include Western blotting for cleaved CASP3 detection, flow cytometry to measure apoptosis and viability, RT-qPCR for gene expression analysis, co-immunoprecipitation with SET, chromatin immunoprecipitation for histone interactions, and immunofluorescence to assess nuclear localization. These assays enable comprehensive characterization of the knockout phenotype. For additional information or technical assistance, please contact Ascent Research.
